8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
An independent comparison of Alloy and its top alternatives for menopause hormone therapy, covering cost, prescribing scope, clinical evidence, and which platform fits each patient profile.
An independent, evidence-based review of Alloy, a direct-to-consumer telehealth platform specializing in menopause hormone therapy (HRT) for women. Covers cost, prescribing practices, clinical legitimacy, and how Alloy compares to alternatives.
An independent clinical assessment of Alloy's menopause and HRT telehealth platform, including who benefits most, cost breakdown, prescribing scope, and how it compares to alternatives.
An independent, current review of Alloy's menopause telehealth intake, prescription process, pricing, products, clinical trade-offs, and alternatives.
Independent pricing breakdown of Alloy's menopause and HRT treatments, including consultation fees, medication costs, and how Alloy compares to alternatives on total annual spend.
Critical, evidence-based analysis of Alloy's menopause and HRT telehealth platform. Real outcomes data, clinical context, and how Alloy compares to alternatives.
An independent clinical assessment of Alloy Women's menopause HRT platform: prescribing model, compounded hormone safety, regulatory standing, cost, and how it compares to alternatives.
An independent clinical review of Alloy's menopause HRT platform, covering prescribing scope, formulary limits, monitoring gaps, and how it compares to alternatives.